Cargando…

Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies

Detalles Bibliográficos
Autores principales: Squire, Jacqueline D., Joshi, Avni Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294866/
https://www.ncbi.nlm.nih.gov/pubmed/34291391
http://dx.doi.org/10.1007/s10875-021-01101-8
_version_ 1783725317461901312
author Squire, Jacqueline D.
Joshi, Avni Y.
author_facet Squire, Jacqueline D.
Joshi, Avni Y.
author_sort Squire, Jacqueline D.
collection PubMed
description
format Online
Article
Text
id pubmed-8294866
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82948662021-07-22 Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies Squire, Jacqueline D. Joshi, Avni Y. J Clin Immunol Letter to Editor Springer US 2021-07-22 2021 /pmc/articles/PMC8294866/ /pubmed/34291391 http://dx.doi.org/10.1007/s10875-021-01101-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to Editor
Squire, Jacqueline D.
Joshi, Avni Y.
Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title_full Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title_fullStr Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title_full_unstemmed Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title_short Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
title_sort safety of covid-19 vaccination in immune-deficient patients receiving supplemental immunoglobulin therapies
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294866/
https://www.ncbi.nlm.nih.gov/pubmed/34291391
http://dx.doi.org/10.1007/s10875-021-01101-8
work_keys_str_mv AT squirejacquelined safetyofcovid19vaccinationinimmunedeficientpatientsreceivingsupplementalimmunoglobulintherapies
AT joshiavniy safetyofcovid19vaccinationinimmunedeficientpatientsreceivingsupplementalimmunoglobulintherapies